Bacterial sialadenitis Market
Description
Bacterial sialadenitis Market, By Type of Bacteria (Staphylococcus aureus, Streptococcus viridans, Pseudomonas aeruginosa, Escherichia coli, Others), By Treatment Type (Antibiotics, Surgery, Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Sialadenitis is swelling and enlargement of the major salivary glands, the parotid (in front of each ear), submandibular (under the tongue on the floor of the mouth) or sublingual (below the tongue in the back of the mouth). It can be acute (sudden) or chronic (long-term) or recurrent. The condition can be caused by infection or by a blockage of the gland's ducts. A common cause of bacterial sialadenitis is Staphylococcus aureus, but other organisms may also be responsible. Bacterial sialadenitis is usually painful and may be accompanied by fever and chills. The affected gland is swollen, red and tender and usually has a central area of discoloration, which may indicate an abscess.
Market Dynamics:
The global Sialadenitis market is expected to witness significant growth in the coming years owing to rising incidence of conditions such as salivary gland infections, sialolithiasis, and autoimmune diseases such as Sjogren’s syndrome.
High cost of treatment and complications associated with the infection are expected to hinder growth of the global bacterial sialadenitis market over the forecast.
Key features of the study:
This report provides in-depth analysis of the global bacterial sialadenitis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bacterial sialadenitis market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Johnson & Johnson, Abbott Laboratories, Eli Lilly and Company, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., and Allergan plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global bacterial sialadenitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacterial sialadenitis market
Detailed Segmentation:
Global Bacterial Sialadenitis Market, By Type of Bacteria:
Staphylococcus aureus
Streptococcus viridans
Pseudomonas aeruginosa
Escherichia coli
Others
Global Bacterial Sialadenitis Market, By Treatment Type:
Antibiotics
Surgery
Others
Global Bacterial Sialadenitis Market, By End-User:
Hospitals and Clinics
Ambulatory Surgical Centers
Others
Global Bacterial Sialadenitis Market, By Geography:
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Company Profiles:
Pfizer Inc.
Merck & Co., Inc.
GlaxoSmithKline plc
Novartis AG
Sanofi S.A.
Johnson & Johnson
Abbott Laboratories
Eli Lilly and Company
AstraZeneca plc
Bayer AG
Bristol-Myers Squibb Company
Roche Holding AG
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Allergan plc.
Table of Contents
130 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type of Bacteria
- Market Snapshot, By Treatment Type
- Market Snapshot, By End User
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Growing prevalence of sialadenitis
- Rise in healthcare expenditure
- Restraints
- Complications related to the infection
- Opportunities
- Increasing research and development activities
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- 4. Global Bacterial Sialadenitis Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- 5. Global Bacterial Sialadenitis Market , By Type of Bacteria, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2023 – 2030
- Segment Trends
- Staphylococcus aureus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Streptococcus viridans
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Pseudomonas aeruginosa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Escherichia coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- 6. Global Bacterial Sialadenitis Market , By Treatment Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018– 2030
- Segment Trends
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
- Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
- 7. Global Bacterial Sialadenitis Market , By End User, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018– 2030
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
- 8. Global Bacterial Sialadenitis Market , By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2023–2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- 9. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
- 10. Section
- Research Methodology
- About us
- *Browse 24 market data tables and 28 figures on “Global Bacterial Sialadenitis Market” - Global forecast to 2030
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
